BNP Paribas Financial Markets’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History
Bought
Maintained
Sold
BNP Paribas Financial Markets's BTX.WS Position: Q3 2018 in Review
BNP Paribas Financial Markets sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 111 shares — an estimated $7 sold.
BNP Paribas Financial Markets first reported a position in BTX.WS in Q4 2017 and held it in 3 quarters. The position peaked at $14 in Q4 2017. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.
- BNP Paribas Financial Markets reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
- BNP Paribas Financial Markets sold 111 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018, an estimated $7.
- BNP Paribas Financial Markets first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2017 and held it in 3 quarters.
- BNP Paribas Financial Markets's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $14 in Q4 2017.
- 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2018, filed 7 Nov 2018.